Investigation of the differences between various renal tumor portions in MRI and tissue examination
Résumé de l'étude
The therapy and prognosis of renal tumors strongly depend on the exact tumor type, which is determined by biopsy, especially in patients whose tumors have already formed metastases and in very old and sick patients. Due to possible differences between various tumor portions, assessment based on a single tissue sample is often difficult. Magnetic resonance imaging (MRI) allows for a very precise representation of the tumor. Thanks to new techniques, statements about the tissue composition in the tumor are also possible, which could provide insights into its aggressiveness and thus the patient's prognosis. This could enable targeted tissue samples from the most aggressive portions and thus a better assessment of the prognosis.
(BASEC)
Intervention étudiée
Patients included in the study will undergo an MRI examination, which will include not only standard sequences but also some new study techniques. No additional contrast agent will be administered.
(BASEC)
Maladie en cours d'investigation
The study aims to improve the diagnostic assessment of renal tumors.
(BASEC)
The following patients may be included in the study: - Patients suspected of having a renal tumor with a minimum size of approximately 2 cm - Patient age ≥ 18 years - Patient's consent to the study (BASEC)
Critères d'exclusion
Patients who meet any of the following statements unfortunately cannot participate in the study: - Pregnant or breastfeeding women - Lack of ability to participate in the study due to language problems, mental illnesses, dementia, etc. - Presence of non-MRI-compatible metallic or electronic implants (pacemakers, shrapnel or other metallic foreign bodies, neurostimulators, etc.). (BASEC)
Lieu de l’étude
Zurich
(BASEC)
Sponsor
University Hospital Zurich
(BASEC)
Contact pour plus d'informations sur l'étude
Personne de contact en Suisse
PD Dr. A. Hötker
+41 43 254 41 10
radiologie@clutterusz.chUniversity Hospital Zurich
(BASEC)
Informations scientifiques
non disponible
Nom du comité d'éthique approbateur (pour les études multicentriques, uniquement le comité principal)
Commission cantonale de Zurich
(BASEC)
Date d'approbation du comité d'éthique
05.08.2022
(BASEC)
Identifiant de l'essai ICTRP
non disponible
Titre officiel (approuvé par le comité d'éthique)
Tumor heterogeneity of renal tumors assessed by multiparametric MRI with direct radiological-histopathological correlation: an explorative study (BASEC)
Titre académique
non disponible
Titre public
non disponible
Maladie en cours d'investigation
non disponible
Intervention étudiée
non disponible
Type d'essai
non disponible
Plan de l'étude
non disponible
Critères d'inclusion/exclusion
non disponible
non disponible
Critères d'évaluation principaux et secondaires
non disponible
non disponible
Date d'enregistrement
non disponible
Inclusion du premier participant
non disponible
Sponsors secondaires
non disponible
Contacts supplémentaires
non disponible
ID secondaires
non disponible
Résultats-Données individuelles des participants
non disponible
Informations complémentaires sur l'essai
non disponible
Résultats de l'essai
Résumé des résultats
non disponible
Lien vers les résultats dans le registre primaire
non disponible